检索结果-南通市图书馆

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV) infected pneumonia(standard version)

在线全文

学校读者我要写书评

暂无评论

Military Medical Research 2020年第1期7卷 1-22页

作者： ying-Hui jin lin Cai Zhen-Shun Cheng Hong Cheng Tong Deng Yi-Pin Fan Cheng fang Di Huang Lu-Qi Huang Qiao Huang Yong Han Bo Hu Fen Hu Bing-Hui li Yi-Rong li Ke liang li-Kai lin li-Sha Luo jing Ma lin-Lu Ma zhi-Yong Peng Yun-Bao Pan Zhen-Yu Pan Xue-Qun Ren Hui-Min Sun ying wang Yun-Yun wang Hong Weng Chao-Jie Wei Dong-fang Wu Jian Xia Yong xiong Hai-Bo Xu Xiao-Mei Yao Yu-Feng Yuan Tai-Sheng ye Xiao-Chun zhang ying-Wen zhang Yin-Gao zhang Hua-Min zhang Yan Zhao ming-Juan Zhao Hao Zi Xian-Tao Zeng Yong-Yan wang Xing-Huan wang 无 Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Institute of Hospital Management Wuhan UniversityWuhan 430071China Department of Respiratory Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Pharmacy Zhongnan Hospital of Wuhan UniversityWuhan 430071China Institute of Evidence-Based Medicine and Knowledge Translation Henan UniversityKaifeng 475000China China Academy of Chinese Medical Sciences Beijing 100700China China Center for Evidence Based Traditional Chinese Medicine(CCEBTCM) Beijing 100700China Department of Critical Care Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Clinical Laboratory Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Infectious Diseases Zhongnan Hospital of Wuhan UniversityWuhan 430071China Division of Medical Affairs Zhongnan Hospital of Wuhan UniversityWuhan 430071China Division of Nursing Affairs Zhongnan Hospital of Wuhan UniversityWuhan 430071China Office of Nosocomial Infection Control Zhongnan Hospital of Wuhan UniversityWuhan 430071China Emergency Center Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Radiology Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Health Research Methods Evidenceand ImpactMcMaster UniversityHamiltonON L8S 4L8Canada Department of Traditional Chinese Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Global Health Institute Wuhan UniversityWuhan 430072China the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care(CPAM)

In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province;and then named "2019 novel coronavirus(2019-nCoV)" by the World Health Organization(WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world’s attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development;we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control(including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.

关键词： 2019 novel coronavirus 2019-nCoV Respiratory disease Pneumonia Infectious diseases Rapid advice guideline Clinical practice guideline Evidence-based medicine

The first data release(DR1) of the LAMOST regular survey

在线全文

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2015年第8期15卷 1095-1124页

作者： A-li Luo Yong-Heng Zhao Gang Zhao li-Cai Deng Xiao-Wei liu Yi-Peng jing Gang wang Hao-Tong zhang Jian-Rong Shi Xiang-Qun Cui Yao-Quan Chu Guo-Ping li Zhong-Rui Bai Yue Wu Yan Cai Shu-Yun Cao Zi-Huang Cao Jeffrey L.Carlin Hai-Yuan Chen Jian-Jun Chen Kun-Xin Chen li Chen Xue-Lei Chen Xiao-Yan Chen ying Chen Norbert Christlieb Jia-Ru Chu Chen-Zhou Cui Yi-Qiao Dong Bing Du Dong-Wei Fan Lei Feng Jian-Ning Fu Peng Gao Xue-Fei Gong Bo-Zhong Gu Yan-Xin Guo zhan-Wen Han Bo-liang He jin-liang Hou Yong-Hui Hou Wen Hou Hong-Zhuan Hu Ning-Sheng Hu Zhong-Wen Hu zhi-ying Huo Lei Jia fang-Hua Jiang Xiang Jiang zhi-Bo Jiang Ge jin Xiao Kong Xu Kong Ya-Juan Lei Ai-Hua li Chang-Hua li Guang-Wei li Hai-Ning li Jian li Qi li Shuang li Sha-Sha li Xin-Nan li Yan li Yin-Bi li ye-Ping li Yuan liang Chien-Cheng lin Chao liu Gen-Rong liu Guan-Qun liu zhi-Gang liu Wen-zhi Lu Yu Luo Yin-Dun Mao Heidi Newberg Ji-Jun Ni Zhao-Xiang Qi Yong-Jun Qi Shi-Yin Shen Huo-ming Shi jing Song Yi-Han Song Ding-Qiang Su Hong-Jun Su Zheng-Hong Tang Qing-Sheng Tao Yuan Tian Dan wang Da-Qi wang Feng-Fei wang Guo-Min wang Hai wang Hong-Chi wang Jian wang Jia-Ning wang Jian-ling wang Jian-Ping wang Jun-Xian wang Lei wang Meng-Xin wang Shou-Guan wang Shu-Qing wang Xia wang Ya-Nan wang You wang Yue-Fei wang You-Fen wang Peng Wei ming-zhi Wei Hong Wu Ke-Fei Wu Xue-Bing Wu Yu-Zhong Wu Xiao-Zheng Xing ling-Zhe Xu Xin-Qi Xu Yan Xu Tai-Sheng Yan De-Hua Yang Hai-Feng Yang Hui-Qin Yang ming Yang Zheng-Qiu Yao Yong Yu Hui Yuan Hai-Bo Yuan Hai-Long Yuan Wei-Min Yuan Chao Zhai En-Peng zhang Hua-Wei zhang Jian-Nan zhang li-Pin zhang Wei zhang Yong zhang Yan-Xia zhang Zheng-Chao zhang ming Zhao fang Zhou Xu Zhou Jie Zhu Yong-Tian Zhu Si-Cheng Zou fang Zuo National Astronomical Observatories Chinese Academy of Sciences Department of Astronomy Peking University Shanghai Astronomical Observatory Chinese Academy of Sciences Nanjing Institute of Astronomical Optics & Technology National Astronomical ObservatoriesChinese Academy of Sciences University of Science and Technology of China Department of Physics Applied Physics and AstronomyRensselaer Polytechnic InstituteTroyNY 12180USA Department of Physics and Astronomy Earlham CollegeRichmondIN 47374USA Universitt Heidelberg Zentrum für AstronomieLandessternwarteKnigstuhl 1269117 HeidelbergGermany Department of Astronomy Beijing Normal University Yunnan Observatories Chinese Academy of Sciences Purple Mountain Observatory Chinese Academy of Sciences

The Large sky Area Multi-Object Fiber Spectroscopic Telescope（LAMOST） general survey is a spectroscopic survey that will eventually cover approximately half of the celestial sphere and collect 10 million spectra of stars, galaxies and QSOs. Objects in both the pilot survey and the first year regular survey are included in the LAMOST DR1. The pilot survey started in October 2011 and ended in June 2012, and the data have been released to the public as the LAMOST Pilot Data Release in August 2012. The regular survey started in September 2012, and completed its first year of operation in June 2013. The LAMOST DR1 includes a total of 1202 plates containing 2 955 336 spectra, of which 1 790 879 spectra have observed signalto-noise ratio（SNR） ≥ 10. All data with SNR ≥ 2 are formally released as LAMOST DR1 under the LAMOST data policy. This data release contains a total of 2 204 696 spectra, of which 1 944 329 are stellar spectra, 12 082 are galaxy spectra and 5017 are quasars. The DR1 not only includes spectra, but also three stellar catalogs with measured parameters： late A,FGK-type stars with high quality spectra（1 061 918 entries）, A-type stars（100 073 entries）, and M-type stars（121 522 entries）. This paper introduces the survey design, the observational and instrumental limitations, data reduction and analysis, and some caveats. A description of the FITS structure of spectral files and parameter catalogs is also provided.

关键词： techniques: spectroscopic survey—data release—catalog

Timing analysis of the black hole candidate EXO 1846–031 with Insight-HXMT monitoring

在线全文

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2021年第3期21卷 193-204页

作者： He-Xin liu Yue Huang Guang-Cheng Xiao Qing-Cui Bu jin-Lu Qu Shu zhang Shuang-Nan zhang Shu-Mei Jia fang-Jun Lu Xiang Ma lian Tao Wei zhang li Chen li-ming Song Ti-Pei li Yu-Peng Xu Xue-Lei Cao Yong Chen Cong-zhan liu Ce Cai zhi Chang Gang Chen Tian-Xiang Chen Yi-Bao Chen Yu-Peng Chen Wei Cui Wei-Wei Cui jing-Kang Deng Yong-Wei Dong Yuan-Yuan Du Min-Xue Fu Guan-Hua Gao He Gao Min Gao ming-Yu Ge Yu-Dong Gu Ju Guan Cheng-Cheng Guo Da-Wei Han Jia Huo Lu-Hua Jiang Wei-Chun Jiang jing jin Yong-Jie jin ling-Da Kong Bing li Cheng-Kui li Gang li Mao-Shun li Wei li Xian li Xiao-Bo li Xu-fang li Yang-Guo li Zheng-Wei li Xiao-Hua liang jing-Yuan liao Bai-Sheng liu Guo-Qing liu Hong-Wei liu Xiao-jing liu Yi-Nong liu Bo Lu Xue-Feng Lu Qi Luo Tao Luo Bin Meng Yi Nang Jian-Yin Nie Ge Ou Na Sai Ren-Cheng Shang Xin-ying Song liang Sun ying Tan You-li Tuo Chen wang Guo-Feng wang Juan wang ling-Jun wang Weng-Shuai wang Yu-Sa wang Xiang-Yang Wen Bai-Yang Wu Bo-Bing Wu Mei Wu Shuo Xiao Shao-lin xiong He Xu Jia-Wei Yang Sheng Yang Yan-Ji Yang Yi-Jung Yang Qi-Bin Yi Qian-Qing Yin Yuan You Ai-Mei zhang Cheng-Mo zhang Fan zhang Hong-Mei zhang Juan zhang Tong zhang Wan-Chang zhang Wen-Zhao zhang Yi zhang Yi-Fei zhang Yong-Jie zhang Yuan-Hang zhang Yue zhang Zhao zhang zhi zhang Zi-liang zhang Hai-Sheng Zhao Xiao-Fan Zhao Shi-Jie Zheng Yao-Guang Zheng Deng-Ke Zhou Jian-Feng Zhou Yu-Xuan Zhu Ren-lin Zhuang Yue Zhu Key Laboratory of Particle Astrophysics Institute of High Energy PhysicsChinese Academy of SciencesBeijing 100049China University of Chinese Academy of Sciences Chinese Academy of SciencesBeijing 100049China Institut fur Astronomie und Astrophysik Kepler Center for Astro and Particle PhysicsEberhard Karls Universität72076 TubingenGermany Department of Astronomy Beijing Normal UniversityBeijing 100088China Department of Astronomy Tsinghua UniversityBeijing 100084China Department of Physics Tsinghua UniversityBeijing 100084China Department of Engineering Physics Tsinghua UniversityBeijing 100084China Key Laboratory of Space Astronomy and Technology National Astronomical ObservatoriesChinese Academy of SciencesBeijing 100101China College of Physics Sciences&Technology Hebei UniversityBaoding 071002Hebei ProvinceChina

We present the observational results from a detailed timing analysis of the black hole candidate EXO 1846-031 during its outburst in 2019 with the observations of Insight-HXMT,NICER and *** outburst can be classified roughly into four different ***-C quasi-periodic oscillations(QPOs)observed by NICER(about 0.1-6 Hz)and Insight-HXMT(about 0.7-8 Hz)are also reported in this ***,we study various physical quantities related to QPO *** QPO rms-frequency relationship in the energy band 1-10 keV indicates that there is a turning pointing in frequency around2 Hz,which is similar to that of GRS 1915+105.A possible hypothesis for the relationship above may be related to the inclination of the source,which may require a high inclination to explain *** relationships between QPO frequency and QPO rms,hardness,total fractional rms and count rate have also been found in other transient sources,which can indicate that the origin of type-C QPOs is non-thermal.

关键词： X-ray binaries black hole candidate QPO EXO 1846–031

Consensus statement on layout and delivery of automatic external defibrillator in China

在线全文

学校读者我要写书评

暂无评论

Journal of Hainan Medical University 2020年第15期26卷 18-23页

作者： Yu Cao Song Chen Yan-Fen Chai Xiao-Hui Chen Yu-Guo Chen Shao-Wen Cheng Wen-Wei Cheng Bang-Han Ding Yang Deng Jie Fu Bang-Jiang fang Mai-ying Fan li Gui Ping Gong Wei Guo Shu-Bin Guo liang Huang Ji-Yuan Han Zhong Ji Xian-Fei Ji Xin-Cai Ji Hong-Xu jin Xin-Jun Jiang wang-Xiang Jiang Jia-liang liu Xiao-Ran liu zhi liu Chuan-Zhu Lv Feng Lu Tan-Shi li Xin li Yong li Shang-Lun li Shuang-ming li Xiao-Gang li Bao-Jun li Pei-Wu li Chun-Sheng li zhi-Jun li Chang-Luo li Xiang-Min li Yin-Ping li Zong-Jun Lu Zu-Xun Lu Zhong-Qiu Lu zhi-Qian Luo Xiao-Xing liao Jian-Bo Lei Tao Ma Yu Ma Yue-Feng Ma Qing-Bian Ma lin-Hao Ma Jun-Qi Ma Shi-Nan Nie Jie-Miao Ou-Yang Peng Peng Qiao Pei Shu-ming Pan Guo-Zhong Qing li-Jie Qin Wu-ying Qiao Fei Shao Wei Song Xing-Yue Song Zhen-Ju Song Rong-Ju Sun De-Ya Shang Du-Juan Sha Gui-Lan Tao Guo-Gang Tian ying-Ping Tian Jian-Guang Tian Chao-Yang Tong Zi-Ren Tang Meng-xiong Tang Guo-Ping Wu zhi Wan Tao wang Xin wang Peng wang Zhong wang Tong wang Ri-Xing wang Yi-Xin wang Xiao-Dan wang ling Wu Wei Wei Hua Xiang Feng Xu Jun Xu Jie Xu Miao-Rong Xie Shuo-Gui Xu Tie Xu Feng Yu Wen Yi li-Shan Yang Shi-Jiao Yan jin-Jian Yao Shou-Chun Yan Xue-Zhong Yu Xian-zhi ye Xian-liang Yan Fu-Bing Zhou Rong-Bin Zhou ming Zhou Qiang Zhou jin Zhou Ping Zhou Chang-Ju Zhu Hua-Dong Zhu Ji-Hong Zhu Hong zhang Mao zhang Hua zhang Na zhang Guo-Qiang zhang Guo-Xiu zhang jin-Song zhang Wen-Wu zhang Wen-Zhong zhang Jian-Feng zhang Yi-Min Zhu Jun Zeng Yuan Zheng zhi-Jie Zheng Shen Zhao Yan Zhao Min Zhao Bin Zhao Xiao-Dong Zhao Xiao-jing Zhao Hong-Ke Zeng Sheng-Qiang Zou The Chinese Society of Emergency Medicine Research Unit of Island Emergency Medicine Chinese Academy of Medical SciencesHainan Medical University Key Laboratory of Emergency and Trauma of Ministry of Education Hainan Medical UniversityHaikouHainanChina Emergency and Trauma College Hainan Medical UniversityHaikouHainanChina Department of Emergency Hainan Clinical Research Center for Acute and Critical DiseasesThe Second Affiliated Hospital of Hainan Medical UniversityHaikouHainanChina Key Laboratory of Hainan Trauma and Disaster Rescue Key Laboratory of Trauma of Hainan Medical University

*** Sudden cardiac death(SCD)refers to sudden death due to a variety of cardiac *** is manifested as a sudden loss of consciousness,cardiac arrest,and respiratory arrest and generally shows early symptoms that are atypical and not easily detected[1].According to a recent study,nearly 544000 patients suffer from SCD every year in China[2].

关键词： cardiac death respiratory

CEPC Technical Design Report

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Radiation Detection Technology and Methods 2024年第1期8卷 I0003-I0016,1-1091页

作者： Waleed Abdallah Tiago Carlos Adorno de Freitas Konstantin Afanaciev Shakeel Ahmad Ijaz Ahmed Xiaocong Ai Abid Aleem Wolfgang Altmannshofer Fabio Alves Weiming An Rui An Daniele Paolo Anderle Stefan Antusch Yasuo Arai Andrej Arbuzov Abdesslam Arhrib Mustafa Ashry Sha Bai Yu Bai Yang Bai Vipul Bairathi Csaba Balazs Philip Bambade Yong Ban Tripamo Bandyopadhyay Shou-Shan Bao Desmond P.Barber Ayse Bat Varvara Batozskaya Subash Chandra Behera Alexander Belyaev Michele Bertucci Xiao-Jun Bi Yuanjie Bi Tianjian Bian Fabrizio Bianchi Thomas Biekotter Michela Biglietti Shalva Bilanishvili Deng Binglin Denis Bodrov Anton Bogomyagkov Serge Bondarenko Stewart Boogert Maarten Boonekamp Marcello Borri Angelo Bosotti Vincent Boudry Mohammed Boukidi Igor Boyko Ivanka Bozovic Giuseppe Bozzi Jean-Claude Brient Anastasiia Budzinskaya Masroor Bukhari Vladimir Bytev Giacomo Cacciapaglia Hua Cai Wenyong Cai Wujun Cai Yijian Cai Yizhou Cai Yuchen Cai Haiying Cai Huacheng Cai Lorenzo Calibbi Junsong Cang Guofu Cao Jianshe Cao Antoine Chance Xuejun Chang Yue Chang Zhe Chang Xinyuan Chang Wei Chao Auttakit Chatrabhuti Yimin Che Yuzhi Che Bin Chen Danping Chen Fuqing Chen Fusan Chen Gang Chen Guoming Chen Hua-Xing Chen Huirun Chen jinhui Chen Ji-Yuan Chen Kai Chen Mali Chen mingjun Chen mingshui Chen Ning Chen Shanhong Chen Shanzhen Chen Shao-Long Chen Shaomin Chen Shiqiang Chen Tianlu Chen Wei Chen Xiang Chen Xiaoyu Chen Xin Chen Xun Chen Xurong Chen ye Chen ying Chen Yukai Chen Zelin Chen Zilin Chen Gang Chen Boping Chen Chunhui Chen Hok Chuen Cheng Huajie Cheng Shan Cheng Tongguang Cheng Yunlong Chi Pietro Chimenti Wen Han Chiu Guk Cho ming-Chung Chu Xiaotong Chu Ziliang Chu Guglielmo Coloretti Andreas Crivellin Hanhua Cui Xiaohao Cui Zhaoyuan Cui Brunella D'Anzi ling-Yun Dai Xinchen Dai Xuwen Dai Antonio De Maria Nicola De Filippis Christophe De La Taille Francesca De Mori Chiara De Sio Elisa Del Core Shuangxue Deng Wei-Tian Deng zhi Deng Ziyan Deng Bhupal Dev Tang Dewen Biagio Di Micco Ran Ding Siqin Dingl Yadong Ding Haiyi Dong Jianin AGH University of Science and Technology Faculty of Physics and Applied Computer ScienceKrakow Anhui University HefeiAnhui Applied Physics Department Federal Urdu University of ArtsScience and TechnologyIslamabad Banaras Hindu University Institute of ScienceVaranasi Bandirma Onyedi Eylul University Bandirma Beihang University Beijing Beijing Computational Science Research Center Beijing Beijing Conveyi LTD Beijing Beijing Glass Research Institute Co. LtdBeijing Beijing Institute of Technology Beijing Beijing Normal University Beijing Brown University ProvidenceRI Budker Institute of Nuclear Physics Novosibirsk Cadi Ayyad University Laboratory of Fundamental and Applied PhysicsPolydisciplinary FacultyMarrakech Cairo University Giza Center for Theory and Computation National Tsing Hua UniversityHsinchu Central China Normal University WuhanHubei Central South University ChangshaHunan Centro de Fisica Teorica de Particulas Universidade Tecnica de LisboaLisboa Chengdu KaitengSifang Digital Radio&TV Equipment Co. LtdChengduSichuan China academy of engineering physics MianyangSichuan China building materials academy Beijing China Center of Advanced Science and Technology Beijing China Institute of Atomic Energy Beijing China Jiliang University HangzhouZhejiang China Nuclear Instrument CO. LTDBeijing China University of Geosciences Beijing China University of Geosciences WuhanHubei China University of Mining and Technology XuzhouJiangsu China West Normal University NanchongSichuan Chongqing University Department of PhysicsChongqing Chulalongkorn University Bangkok City University of Hong Kong Department of PhysicsHong Kong Cockcroft Institute Daresbury Cornell University IthacaNY CPPM(AMU/IPhU&CNRS/INP) Marseille Dalian Minzu University DalianLiaoning Dalian University of Technology Department of PhysicsDalian Deutsches Elektronen-Synchrotron DESY Hamburg Dzhelepov Laboratory of Nuclear Problems of Joint Institute for Nuclear Research(DLNP jinR) Dubna East China University Of Science And Technol

The Circular Electron Positron Collider(CEPC)is a large scientific project initiated and hosted by China,fostered through extensive collaboration with international *** complex comprises four accelerators:a 30 GeV linac,a 1.1 GeV Damping Ring,a Booster capable of achieving energies up to 180 GeV,and a Collider operating at varying energy modes(Z,W,H,and tt).The linac and Damping Ring are situated on the surface,while the subterranean Booster and Collider are housed in a 100 km circumference underground tunnel,strategically accommodating future expansion with provisions for a potential Super Proton Proton Collider(SPPC).The CEPC primarily serves as a Higgs *** its baseline design with synchrotron radiation(SR)power of 30 MW per beam,it can achieve a luminosity of 5×10^(34)cm^(-2)s^(-1)per interaction point(IP),resulting in an integrated luminosity of 13 ab^(-1)for two IPs over a decade,producing 2.6 million Higgs *** the SR power to 50 MW per beam expands the CEPC's capability to generate 4.3 million Higgs bosons,facilitating precise measurements of Higgs coupling at sub-percent levels,exceeding the precision expected from the HL-LHC by an order of *** Technical Design Report(TDR)follows the Preliminary Conceptual Design Report(Pre-CDR,2015)and the Conceptual Design Report(CDR,2018),comprehensively detailing the machine's layout,performance metrics,physical design and analysis,technical systems design,R&D and prototyping efforts,and associated civil engineering ***,it includes a cost estimate and a preliminary construction timeline,establishing a framework for forthcoming engineering design phase and site selection *** is anticipated to begin around 2027-2028,pending government approval,with an estimated duration of 8 *** commencement of experiments and data collection could potentially be initiated in the mid-2030s.

关键词： initiated exceeding precise

柳氮磺吡啶在我国类风湿关节炎患者的用药现况调查

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

北京大学学报（医学版） 2012年第2期44卷 188-194页

作者：刘田王秀茹安媛周云杉张晓盈段天骄朱佳鑫李晓峰王莉枝王彩虹王永福杨荣王国春卢昕朱平陈丽娜靳洪涛刘湘源孙琳陈海英崔刘福舒荣刘白鹭张卓莉李光韬李振彬杨静李俊芳贾彬张风肖陶杰梅韩淑玲林金盈韦美秋刘晓敏柯丹胡绍先叶丛杨岫岩李昊黄慈波高明赖蓓李兴福宋立军王轶王晓元穆荣苏茵栗占国北京大学人民医院风湿免疫科北京100044 北京大学首钢医院多顶街社区卫生中心全科山西医科大学第二医院风湿免疫科太原030001 包头医学院第一附属医院风湿免疫科包头014010 中日友好医院风湿免疫科北京100029 第四军医大学西京医院风湿免疫科西安710032 河北医科大学第二医院风湿免疫科石家庄050000 北京大学第三医院风湿免疫科北京100191 河北医科大学第三医院风湿免疫科石家庄050051 华北煤炭医学院附属开滦医院风湿免疫科唐山063000 北京大学第一医院风湿免疫科北京100034 白求恩国际和平医院风湿免疫科石家庄050082 河北邯郸中心医院风湿免疫科邯郸056001 河北省人民医院风湿免疫科石家庄050051 北京大学首钢医院风湿免疫科北京100144 广西壮族自治区人民医院风湿免疫科南宁530021 北京顺义区医院风湿免疫科北京101300 华中科技大学同济医学院附属同济医院风湿免疫科武汉430030 中山医科大学附属第一医院风湿免疫科广州510080 北京医院风湿免疫科北京100730 山东大学齐鲁医院风湿免疫科济南250012 兰州大学第二医院风湿免疫科兰州730030

目的:调查和分析类风湿关节炎(rheumatoid arthritis,RA)患者治疗中柳氮磺吡啶(sulphasalazine,SSZ)的使用及其不良反应发生情况。方法:采用流行病学现况调查的研究方法,对北京大学人民医院等全国21家三级甲等医院2009年7月至2010年12... 详细信息

目的:调查和分析类风湿关节炎(rheumatoid arthritis,RA)患者治疗中柳氮磺吡啶(sulphasalazine,SSZ)的使用及其不良反应发生情况。方法:采用流行病学现况调查的研究方法,对北京大学人民医院等全国21家三级甲等医院2009年7月至2010年12月于风湿免疫科门诊及病房就诊的1 096例RA患者进行问卷调查,并详细记录患者的一般资料和临床特点,分析其中160例使用SSZ患者的临床特点、副作用发生情况、SSZ使用现况及联合用药种类和时间等数据。结果:160例患者使用SSZ治疗,使用比例为14.6%。该组患者男女之比为1∶7,平均发病年龄为(46.1±15.0)岁,平均病程为(9.9±7.8)年。SSZ平均用量为(1.87±0.52)g/d,平均用药时间为(26.3±14.6)月。所有患者仅有17%(27/160)使用SSZ单药治疗,其余患者均曾联合应用其他缓解病情抗风湿药(diseasemodifying antirheumatic drugs,DMARDs),其中甲氨蝶呤(methotrexate,MTX)是最常应用的联合治疗药物,占63.1%,平均联合使用MTX时间(28.2±12.3)月;其次为来氟米特(36.2%)和羟氯喹(18.1%);SSZ+MTX是最常见的联合治疗方案(36.2%)。应用SSZ患者的疗效指标优于未应用者。调查时有41.9%(67/160)的患者曾使用SSZ治疗,但因药物不良反应或其他原因而停药。有17.5%(28/160)的患者因不良反应停药,其中因胃肠道反应停药比率(8.8%)最高,其次为皮疹(3.8%)和肝功能异常(3.1%)。结论:与其他国家相比,SSZ在我国应用率偏低,且平均用量上较临床规范用量偏小。SSZ治疗RA不良反应程度较轻,在临床应用中相对比较安全。

关键词：柳氮磺吡啶关节炎,类风湿横断面研究

我国类风湿关节炎患者应用肿瘤坏死因子抑制剂现况调查

在线全文

学校读者我要写书评

暂无评论

北京大学学报（医学版） 2012年第2期44卷 182-187页

作者：王秀茹苏茵安媛周云杉张晓盈段天骄朱佳鑫李小峰王彩虹王莉枝王永福杨荣王国春卢昕朱平陈丽娜王轶王晓元靳洪涛刘金婷陈海英魏平王俊祥刘湘源孙琳崔刘福舒荣刘白鹭张卓莉李光韬李振彬杨静李俊芳贾彬张风肖陶杰梅林金盈韦美秋刘晓敏柯丹胡绍先叶丛韩淑玲杨岫岩李昊黄慈波高明赖蓓李兴福宋立军穆荣栗占国北京大学人民医院风湿免疫科北京100044 北京大学首钢医院多顶街社区卫生中心全科山西医科大学第二医院风湿免疫科太原030001 包头医学院第一附属医院风湿免疫科包头014010 中日友好医院风湿免疫科北京100029 第四军医大学西京医院风湿免疫科西安710032 兰州大学第二医院风湿免疫科兰州730030 河北医科大学第二医院风湿免疫科石家庄050000 河北医科大学第三医院风湿免疫科石家庄050051 北京大学第三医院风湿免疫科北京100191 华北煤炭医学院附属开滦医院风湿免疫科唐山063000 北京大学第一医院风湿免疫科北京100034 白求恩国际和平医院风湿免疫科石家庄050082 河北邯郸中心医院风湿免疫科邯郸056001 河北省人民医院风湿免疫科石家庄050051 广西壮族自治区人民医院风湿免疫科南宁530021 北京顺义区医院风湿免疫科北京101300 华中科技大学同济医学院附属同济医院风湿免疫科武汉430030 北京大学首钢医院风湿免疫科北京100144 中山医科大学附属第一医院风湿免疫科广州510080 北京医院风湿免疫科北京100730 山东大学齐鲁医院风湿免疫科济南250012

目的:了解我国类风湿关节炎(rheumatoid arthritis,RA)患者应用肿瘤坏死因子(tumor necrosis factor,TNF)抑制剂的现状以及影响其应用的因素。方法:采用多中心现况调查问卷调查的方法,记录入选者的一般情况和应用TNF抑制剂的情况,计算... 详细信息

目的:了解我国类风湿关节炎(rheumatoid arthritis,RA)患者应用肿瘤坏死因子(tumor necrosis factor,TNF)抑制剂的现状以及影响其应用的因素。方法:采用多中心现况调查问卷调查的方法,记录入选者的一般情况和应用TNF抑制剂的情况,计算患者应用TNF抑制剂的费用,分析我国TNF抑制剂的应用现状及影响其应用的相关因素。结果:2009年7月至2010年11月期间,共有全国范围内的21家大型医院风湿免疫科就诊的1 095位RA患者完成问卷,其中112位患者应用了TNF抑制剂(infliximab,商品名类克或etanercept,商品名益赛普)进行治疗,占总研究人群的10.2%(其中益赛普81例,占7.4%;类克26例,占2.4%;两种制剂都用过者5例,占0.5%)。应用类克疗程<3个月及3～6个月者均为38.1%,益赛普疗程<3个月及3～6个月者分别占38.5%和25.0%。应用类克疗程<3个月、3～6个月及6～9个月者的健康评估问卷(health assessment question-naire,HAQ)评分分别为1.1、0.5、0.1,益赛普的相应评分分别为1.3、1.0、0.3。应用类克疗程<3个月、3～6个月及6～9个月的费用分别为24 525.0、69 300.0、96 800.0元,益赛普的费用分别为7 394.8、9 158.6、54 910.9元。应用类克疗程<3个月、3～6个月及6～9个月的患者的间接经济损失分别为365.6、0、158.9元,益赛普分别为2 158.4、288.5、180.1元。出现过敏和感染的比例在应用益赛普者均为3.5%,在应用类克者均为6.5%。Logistic回归分析显示,受教育程度是影响TNF抑制剂应用的主要相关因素。结论:在我国大型医院就诊的RA患者中约有10%应用过TNF抑制剂,其病情随应用TNF抑制剂的疗程延长而减轻,治疗总费用随用药疗程延长而增加,但间接经济损失随疗程延长而减少,主要不良反应为过敏和感染,受教育程度是影响其应用的主要相关因素。

关键词：关节炎,类风湿肿瘤坏死因子问卷调查药费支出

中国九城市成人医院获得性肺炎微生物学与临床特点调查

在线全文

学校读者我要写书评

暂无评论

中华结核和呼吸杂志 2012年第10期35卷 739-746页

作者：刘又宁曹彬王辉陈良安佘丹阳赵铁梅梁志欣孙铁英李燕明童朝晖王臻贺蓓杨薇瞿介明李向阳陈荣昌叶枫康健李尔然陈萍郑岩马忠森任锦施毅孙文逵冯玉麟范红姜淑娟张嵩熊盛道左鹏王占伟解放军总医院呼吸科北京100853 首都医科大学附属北京朝阳医院感染和临床微生物科首都医科大学附属北京朝阳医院呼吸科北京大学人民医院检验科卫生部北京医院呼吸与危重症医学科北京大学第三医院呼吸科上海复旦大学附属华东医院呼吸科广州呼吸疾病研究所中国医科大学附属第一医院呼吸疾病研究所沈阳军区总医院呼吸科吉林大学第二医院呼吸科南京军区南京总医院呼吸与危重症医学科四川大学华西医院呼吸科山东省立医院呼吸科武汉同济医院呼吸科

目的探讨我国医院获得性肺炎（HAP）的临床与致病微生物特点，为临床合理治疗提供依据。方法在中国不同城市的13家教学医院进行HAP多中心、前瞻性调查研究。人选2008年8月至2010年12月国内13家大型教学医院呼吸科病房和呼吸科监护病房（... 详细信息

目的探讨我国医院获得性肺炎（HAP）的临床与致病微生物特点，为临床合理治疗提供依据。方法在中国不同城市的13家教学医院进行HAP多中心、前瞻性调查研究。人选2008年8月至2010年12月国内13家大型教学医院呼吸科病房和呼吸科监护病房（RICU）所有确诊为HAP的患者。收集人选患者的临床资料，留取痰或气管吸引物及发热患者的血标本进行常规细菌培养及药敏试验，留取间隔2周以上的双份血清检测军团菌血清抗体，留取尿液检测尿液中肺炎链球菌抗原水平。结果610例HAP患者中，93．9％（573例）合并一种或多种基础疾病，HAP总发生率为1．4％（610／42877），其中呼吸科普通病房的发生率为0．9％（362／41261），RICU的发生率为15．3％（248／1616）。610例中91．0％（555例）的患者在发生HAP前90天内使用过抗菌药物。HAP患者中79．8％（487／610）的患者检测到病原体，首位是鲍曼不动杆菌，占30．0％（183／610），其次为铜绿假单胞菌（22．0％，134／610）、金黄色葡萄球菌（13．4％，82／610）及肺炎克雷伯菌（9．7％，59／610）；18例（3．0％）分离到苛养菌。呼吸机相关肺炎（VAP）中鲍曼不动杆菌和金黄色葡萄球菌的分离率为50．5％（97／192）和21．4％（41／192），显著高于非VAP患者[分别为20．6％（86／418）和9．8％（41／418），均P〈0．01]。急性生理学及慢性健康状况评分II（APACHE1I）评分≥20的患者中，鲍曼不动杆菌和金黄色葡萄球菌的分离率分别为45．7％（69／151）和20．5％（31／151），显著高于APACHEII评分〈20的患者[分别为24．8％（114／459）和11．1％（51／459），均P〈0．01]。鲍曼不动杆菌对碳青霉烯的耐药率高达76．8％（109／142），对头孢哌酮舒巴坦的敏感度为40．8％（58／142），多黏菌素的敏感度为99．3％（141／142），替加环素的敏感度为95．8％（136／142）。铜绿假单胞菌对美罗培南、亚胺培南的耐药率分别为48．8％（40／82）和70．7％（58／82）。金黄色葡萄球菌中甲氧西林耐药的金黄色葡萄球菌（MRSA）占87。8％（43／49）。HAP的平均全因病死率为22．3％（135／605），其中VAP为34．5％（61／177），显著高于平均全因病死率（P〈0．05）。HAP患者的平均住院时间为（23．8±20．5）d，显著高于同期所有住院患者的平均住院时间（13．2±13．6）d（t=18．7498，P〈0．01）。HAP患者总住院治疗费用平均为（108950±116608）元，显著高于同期呼吸科住院患者平均住院费用（17999±33364）元。结论HAP是我国大型教学医院常见的医院内感染，全因病死率较高，可导致住院时间显著延长及住院总费用增高。HAP常见的致病菌主要为鲍曼不动杆菌、铜绿假单胞菌、会黄色葡萄球菌及肺炎克雷伯菌。我国教学医院HAP常见致病菌的耐药情况严雷．值得关沣。

关键词：医院获得性肺炎病原流行病学耐药性

全国多中心类风湿关节炎冠心病危险因素的现况调查

在线全文

学校读者我要写书评

暂无评论

北京大学学报（医学版） 2012年第2期44卷 176-181页

作者：李春王秀茹唐熠达安媛周云杉郭时伟张晓盈段天骄朱佳鑫李晓峰王莉枝王彩虹王永福杨荣王国春卢昕朱平陈丽娜靳洪涛刘金婷刘湘源孙琳陈海英魏平王俊祥崔刘福舒荣刘白鹭张卓莉李光韬李振彬杨静李俊芳贾彬张风肖陶杰梅韩淑玲林金盈韦美秋刘晓敏柯丹胡绍先叶丛杨岫岩李昊黄慈波高明赖蓓李兴福宋立军王轶王晓元穆荣苏茵栗占国北京大学人民医院风湿免疫科北京100044 北京大学首钢医院多顶街社区卫生中心全科中国医学科学院北京协和医学院阜外心血管病医院心内科北京100037 山西医科大学第二医院风湿免疫科太原030001 包头医学院第一附属医院风湿免疫科包头014010 中日友好医院风湿免疫科北京100029 第四军医大学西京医院风湿免疫科西安710032 河北医科大学第二医院风湿免疫科石家庄050000 北京大学第三医院风湿免疫科北京100191 河北医科大学第三医院风湿免疫科石家庄050051 华北煤炭医学院附属开滦医院风湿免疫科唐山063000 北京大学第一医院风湿免疫科北京100034 白求恩国际和平医院风湿免疫科石家庄050082 河北邯郸中心医院风湿免疫科邯郸056001 河北省人民医院风湿免疫科石家庄050051 北京大学首钢医院风湿免疫科北京100144 广西壮族自治区人民医院风湿免疫科南宁530021 北京顺义区医院风湿免疫科北京101300 华中科技大学同济医学院附属同济医院风湿免疫科武汉430030 中山医科大学附属第一医院风湿免疫科广州510080 北京医院风湿免疫科北京100730 山东大学齐鲁医院风湿免疫科济南250012 兰州大学第二医院风湿免疫科兰州730030

目的:了解我国类风湿关节炎(rheumatoid arthritis,RA)患者冠心病(coronary artery disease,CAD)的患病情况并评估其发生的危险因素。方法:调查RA患者冠心病相关的临床资料,包括冠心病的患病情况、冠心病传统危险因素[糖尿病、高血压、... 详细信息

目的:了解我国类风湿关节炎(rheumatoid arthritis,RA)患者冠心病(coronary artery disease,CAD)的患病情况并评估其发生的危险因素。方法:调查RA患者冠心病相关的临床资料,包括冠心病的患病情况、冠心病传统危险因素[糖尿病、高血压、高血脂、吸烟及体重指数(BMI)]及RA临床表现[关节肿胀、疼痛、畸形数目,皮下结节数目,动态红细胞沉降率(erythrocyte sedimentation rate,ESR)、C反应蛋白(C-reactive protein,CRP)、类风湿因子(rheumatoid factor,RF)等]、关节功能状态评分及用药情况。对冠心病组及非冠心病组的危险因素、临床特点及用药情况等方面进行单因素比较及多因素Logistic回归分析。结果:共调查21家医院的960例RA患者,其中女性779人,男性181人,女∶男=4.3∶1,平均年龄(52.7±13.9)岁(11.0～86.0岁)。RA患者冠心病的患病率为3.5%(34/960),其中合并超重和肥胖者占35.1%(377/960)、吸烟者占12.3%(118/960)、高血压者占17.0%(163/960)、糖尿病者占7.7%(74/960)、高胆固醇血症者占0.4%(4/960)、脑血管病者占3.0%(29/960)。冠心病组与非冠心病组相比,年龄高[(64.7±9.3)岁vs.(52.3±14.0)岁,P<0.001]、皮下结节数目多(14.7%vs.3.1%,P=0.005)、肺间质病变发生率高(17.6%vs.7.0%,P=0.034)、羟氯喹(hydroxychloroquine,HCQ)使用比例低(5.9%vs.22.6%,P=0.021)、糖尿病及高血压患病率高(29.4%vs.7.0%,P<0.001;38.2%vs.16.2%,P=0.001),而受检时关节畸形数目、RF水平及糖皮质激素的使用、高胆固醇血症患病率及BMI与冠心病发生无关。经多元Logistic回归分析,高龄、合并糖尿病及高血压为RA合并冠心病的独立危险因素,使用HCQ为RA合并冠心病的保护因素。结论:RA患者冠心病的患病率为3.5%。高龄、合并糖尿病及高血压为其独立危险因素,合并使用HCQ为其保护因素。

关键词：关节炎,类风湿冠心病危险因素患病率